IBRN vs. CNBS ETF Comparison
Comparison of iShares Neuroscience and Healthcare ETF (IBRN) to Amplify Seymour Cannabis ETF (CNBS)
IBRN
iShares Neuroscience and Healthcare ETF
IBRN Description
iShares Neuroscience and Healthcare ETF is an exchange traded fund launched by BlackRock, Inc. It is managed by BlackRock Fund Advisors. The fund invests in public equity markets of global region. It invests in stocks of companies operating across neurology biopharmaceuticals or neurological devices sectors. The fund invests in growth and value stocks of companies across diversified market capitalization. It seeks to track the performance of the NYSE FactSet Global Neuro Biopharma and MedTech Index, by using representative sampling technique. iShares Neuroscience and Healthcare ETF is domiciled in the United States.
Grade (RS Rating)
Last Trade
$25.99
Average Daily Volume
353
9
CNBS
Amplify Seymour Cannabis ETF
CNBS Description
The investment seeks to provide investors capital appreciation. The fund will invest at least 80% of its net assets (including investment borrowings) in the securities of companies that derive 50% or more of their revenue from the cannabis and hemp ecosystem. It is an actively managed ETF that seeks to provide investment exposure to global companies principally engaged in the emerging cannabis and hemp ecosystem across one of three classifications. The fund is non-diversified.Grade (RS Rating)
Last Trade
$3.31
Average Daily Volume
32,101
10
Performance
| Period | IBRN | CNBS |
|---|---|---|
| 30 Days | -4.46% | -24.09% |
| 60 Days | 2.04% | -22.45% |
| 90 Days | 1.20% | -25.61% |
| 12 Months | 24.40% | -18.73% |
0 Overlapping Holdings
| Symbol | Grade | Weight in IBRN | Weight in CNBS | Overlap |
|---|
IBRN: Top Represented Industries & Keywords
CNBS: Top Represented Industries & Keywords
Compare ETFs
